We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$2.27B
AUM Growth
+$198M
Cap. Flow
+$119M
Cap. Flow %
5.25%
Top 10 Hldgs %
35.16%
Holding
449
New
157
Increased
70
Reduced
62
Closed
148

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$170M
2
TMUS icon
T-Mobile US
TMUS
+$71.2M
3
AAP icon
Advance Auto Parts
AAP
+$34.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$27.2M
5
VAL
Valspar
VAL
+$22M

Sector Composition

Rank Sector Weight
1 Consumer Staples 15.94%
2 Healthcare 14.24%
3 Communication Services 13.98%
4 Consumer Discretionary 11.95%
5 Technology 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
126
UnitedHealth
UNH
$382B
$2.58M 0.11%
13,935
+11,361
+441% +$1.99M
PXD
127
DELISTED
Pioneer Natural Resource Co.
PXD
$2.52M 0.11%
+15,775
New +$2.7M
PPL
128
PPL Corp
PPL
$27.3B
$2.52M 0.11%
+64,699
New +$2.5M
ELV icon
129
Elevance Health
ELV
$81.9B
$2.51M 0.11%
+13,361
New +$2.4M
STI
130
DELISTED
SunTrust Banks, Inc.
STI
$2.51M 0.11%
+43,983
New +$2.44M
XELA
131
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$2.5M 0.11%
21
XEC
132
DELISTED
CIMAREX ENERGY CO
XEC
$2.49M 0.11%
26,528
-15,453
-37% -$1.7M
WPX
133
DELISTED
WPX Energy, Inc.
WPX
$2.34M 0.1%
+233,694
New +$2.66M
EVHC
134
DELISTED
Envision Healthcare Holdings Inc
EVHC
$2.3M 0.1%
36,450
+24,593
+207% +$1.42M
L icon
135
Loews
L
$24.3B
$2.28M 0.1%
+48,579
New +$2.28M
PNRA
136
DELISTED
Panera Bread Co
PNRA
$2.27M 0.1%
+7,192
New +$2.25M
CPAAW
137
DELISTED
Conyers Park Acquisition Corp. Warrant
CPAAW
$2.25M 0.1%
+749,979
New +$1.97M
GXP
138
DELISTED
Great Plains Energy Incorporated
GXP
$2.23M 0.1%
+76,983
New +$2.24M
DXC icon
139
DXC Technology
DXC
$1.63B
$2.22M 0.1%
+33,356
New +$2.21M
FCX icon
140
Freeport-McMoran
FCX
$90B
$2.13M 0.09%
+177,205
New +$2.15M
OCLR
141
DELISTED
Oclaro Inc.
OCLR
$2.11M 0.09%
+234,604
New +$2.12M
BG icon
142
Bunge Global
BG
$23.6B
$2.01M 0.09%
+26,744
New +$2.03M
CSX icon
143
CSX Corp
CSX
$98.6B
$1.99M 0.09%
108,405
-569,244
-84% -$9.75M
ESRX
144
DELISTED
Express Scripts Holding Company
ESRX
$1.98M 0.09%
+30,918
New +$1.94M
IBB icon
145
iShares Biotechnology ETF
IBB
$9.31B
$1.96M 0.09%
+18,978
New +$1.87M
DGX icon
146
Quest Diagnostics
DGX
$25.1B
$1.96M 0.09%
17,659
+177
+1% +$18.7K
PM icon
147
Philip Morris
PM
$301B
$1.94M 0.09%
16,594
-47,388
-74% -$5.49M
WDC icon
148
Western Digital
WDC
$179B
$1.9M 0.08%
+28,245
New +$1.88M
GDDY icon
149
GoDaddy
GDDY
$12.3B
$1.84M 0.08%
43,709
+29,880
+216% +$1.2M
AMG icon
150
Affiliated Managers Group
AMG
$9.46B
$1.83M 0.08%
+11,017
New +$1.76M

Similar funds

Marshall Wace's Q2 2017 Portfolio in Review

As of Q2 2017, Marshall Wace held 449 positions worth $2.27B, up 9.6% from $2.07B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace deployed $119M of net new capital in Q2 2017, opening 157 new positions and adding to 70 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 16% of assets, up from 11% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Zoetis, an estimated $170M trimmed.

  • Marshall Wace's largest Q2 2017 buy was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.
  • Marshall Wace added most to Reynolds American Inc in Q2 2017, an estimated $84.2M increase.
  • Marshall Wace's biggest Q2 2017 reduction was Zoetis, cutting an estimated $170M.
  • Marshall Wace fully exited Advance Auto Parts in Q2 2017, selling an estimated $34.1M.
  • Marshall Wace's ten largest holdings make up 35% of its $2.27B portfolio in Q2 2017.
  • Marshall Wace opened 157 new positions and closed 148 in Q2 2017.
  • Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $2.27B.

Based on Marshall Wace's 13F filing for Q2 2017, filed 4 Aug 2017.